Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies

The incidence of esophageal adenocarcinoma (EAC) has rapidly increased, particularly in the Western world. Despite improvements in perioperative treatments, the overall survival of patients remains low. Claudin 18.2 is a tight junction protein that is exclusively expressed in the gastric epithelia....

Descripción completa

Detalles Bibliográficos
Autores principales: Moentenich, Valeska, Gebauer, Florian, Comut, Erdem, Tuchscherer, Armin, Bruns, Christiane, Schroeder, Wolfgang, Buettner, Reinhard, Alakus, Hakan, Loeser, Heike, Zander, Thomas, Quaas, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204493/
https://www.ncbi.nlm.nih.gov/pubmed/32391091
http://dx.doi.org/10.3892/ol.2020.11520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204493/
https://www.ncbi.nlm.nih.gov/pubmed/32391091
http://dx.doi.org/10.3892/ol.2020.11520

Ejemplares similares